Wire Stories
-
426Movella and Advantech Collaborate to Deliver Advanced Solutions for AMR and AGV Applications
HENDERSON, Nev. & TAIPEI, Taiwan–(BUSINESS WIRE)–Leading industrial sensor technology provider Movella and Advantech, a global leader in Industrial IoT, have joined forces...
-
464DK ASIA Advertises Brand in New York Times Square as the First in Korea’s Construction and Development Industry
– K-City: The Newest Wave of Korean Culture – Featuring world star Lee Byung-hun, captivates global audience – Running concurrent global brand...
-
481Core Molding Technologies Reports Fiscal 2023 Third Quarter Results
Strategic Initiatives Continue to Drive Higher Returns and Generate Strong Cash Flow COLUMBUS, Ohio, Nov. 07, 2023 (GLOBE NEWSWIRE) — Core Molding...
-
377Core Molding Technologies Reports Fiscal 2023 Third Quarter Results
Strategic Initiatives Continue to Drive Higher Returns and Generate Strong Cash Flow COLUMBUS, Ohio, Nov. 07, 2023 (GLOBE NEWSWIRE) — Core Molding...
-
307Fabrinet to Present at Needham Virtual Tech Week Conference
BANGKOK–(BUSINESS WIRE)–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment...
-
421LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial
BostonGene to Support Phase 1/2 Clinical Trial of TROP2-Directed Antibody-Drug Conjugate (ADC) in Patients with Advanced Cancers WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, a leading...
-
405Armis Research Finds One-Third of Global Organizations Experienced Multiple Security Breaches in Last 12 Months
40% of assets remain unmonitored and pose the biggest threat to organizations globally SAN FRANCISCO–(BUSINESS WIRE)–Armis, the asset intelligence cybersecurity company, today...
-
408Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
35-subject SWING Trial evaluates the safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated Balloon Updated safety and performance data for the SWING trial...
-
357Gilat Reports Third Quarter 2023 Results
Revenues Grew 6% to $63.9 million;GAAP Operating Income of $12.7 million and Adjusted EBITDA of $9.5 million, 30% Growth Year-over-Year; PETAH TIKVA,...
-
331Gilat Reports Third Quarter 2023 Results
Revenues Grew 6% to $63.9 million;GAAP Operating Income of $12.7 million and Adjusted EBITDA of $9.5 million, 30% Growth Year-over-Year; PETAH TIKVA,...
